# Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy

> **NCT05663801** · PHASE2 · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 72 (actual)

## Conditions studied

- Cancer
- Breast

## Interventions

- **DRUG:** Use of Bupivacaine in pectoral nerve block in mastectomy
- **DRUG:** use of Ketamine as adjuvants to bupivacaine in pectoral nerve block in mastectomy
- **DRUG:** Use of Magnesium Sulfate as adjuvants to bupivacaine in pectoral nerve block in mastectomy

## Key facts

- **NCT ID:** NCT05663801
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05663801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05663801, "Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05663801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*